Your browser doesn't support javascript.
loading
Risk factors for infection after pediatric lung transplantation.
Onyearugbulem, Chinyere; Williams, Lauren; Zhu, Huirong; Gazzaneo, Maria C; Melicoff, Ernestina; Das, Shailendra; Coss-Bu, Jorge; Lam, Fong; Mallory, George; Munoz, Flor M.
Afiliación
  • Onyearugbulem C; Texas Children's Hospital, Houston, Texas.
  • Williams L; Department of Pediatrics, Baylor College of Medicine, Houston, Texas.
  • Zhu H; Section of Critical Care Medicine, Texas Children's Hospital, Houston, Texas.
  • Gazzaneo MC; Texas Children's Hospital, Houston, Texas.
  • Melicoff E; Department of Pediatrics, Baylor College of Medicine, Houston, Texas.
  • Das S; Texas Children's Hospital, Houston, Texas.
  • Coss-Bu J; Outcome and Impact Service, Texas Children's Hospital, Houston, Texas.
  • Lam F; Texas Children's Hospital, Houston, Texas.
  • Mallory G; Department of Pediatrics, Baylor College of Medicine, Houston, Texas.
  • Munoz FM; Section of Critical Care Medicine, Texas Children's Hospital, Houston, Texas.
Transpl Infect Dis ; 20(6): e13000, 2018 Dec.
Article en En | MEDLINE | ID: mdl-30221817
Although infection is the leading cause of death in the first year following pediatric lung transplantation, there are limited data on risk factors for early infection. Sepsis remains under-recognized and under-reported in the early post-operative period for lung transplant recipients (LTR). We evaluated the incidence of infection and sepsis, and identified risk factors for infection in the early post-operative period in pediatric LTRs. A retrospective review of medical records of LTRs at a large quaternary-care hospital from January 2009 to March 2016 was conducted. Microbiology results on days 0-7 after transplant were obtained. Sepsis was defined using the 2005 International Pediatric Consensus Conferencecriteria. Risk factors included history of recipient and donor infection, history of multi-drug resistant (MDR) infection, nutritional status, and surgical times. Among the 98 LTRs, there were 22 (22%) with post-operative infection. Prolonged donor ischemic time ≥7 hours, cardiopulmonary bypass(CPB) time ≥340 minutes, history of MDR infection and diagnosis of cystic fibrosis were significantly associated with infection. With multivariable regression analysis, only prolonged donor ischemic time remained significant (OR 4.4, 95% CI: 1.34-14.48). Further research is needed to determine whether processes to reduce donor ischemic time could result in decreased post-transplant morbidity.
Asunto(s)

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Complicaciones Posoperatorias / Trasplante de Pulmón / Infecciones / Antiinfecciosos Tipo de estudio: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adolescent / Child / Child, preschool / Female / Humans / Male Idioma: En Revista: Transpl Infect Dis Asunto de la revista: TRANSPLANTE Año: 2018 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Complicaciones Posoperatorias / Trasplante de Pulmón / Infecciones / Antiinfecciosos Tipo de estudio: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adolescent / Child / Child, preschool / Female / Humans / Male Idioma: En Revista: Transpl Infect Dis Asunto de la revista: TRANSPLANTE Año: 2018 Tipo del documento: Article